General Session V - Venous Thromboembolism and IVC Filters
We retrospectively reviewed the results of consecutive unilateral lower extremity VDUS for inpatients and outpatients from January 2023 to July 2023. Patient data including age, sex, symptoms, risk factors for DVT, and indications for the VDUS were collected. The primary outcome was frequency of DVT in the asymptomatic contralateral femoral vein. Categorical and continuous data were compared using X2 and Student’s t-tests, respectively. For all tests, a P-value of < 0.05 was considered statistically significant.
Results:
371 patients (170 inpatient vs. 201 outpatient) with unilateral DVT symptoms who underwent VDUS during the study period were identified. Right leg symptoms were present in 186 (50%) patients and left leg symptoms were present in 185 (50%) patients. There was no difference in the prevalence of DVT risk factors or ipsilateral VDUS findings between inpatients and outpatients (Table I). Overall, 119 (32%) patients were found to have a DVT including 118 (31%) unilateral and 1 (0.08%) bilateral. The patient with bilateral acute DVTs was an inpatient admitted for irritable bowel syndrome. VDUS demonstrated a DVT in the femoral vein of the symptomatic limb and calf veins of the asymptomatic limb. There were no patients with a DVT isolated to the asymptomatic contralateral femoral vein.
Conclusions:
Scanning the asymptomatic contralateral femoral vein is not necessary in inpatients or outpatients presenting with unilateral DVT symptoms, regardless of risk factors. A single-extremity study will suffice in most cases without resulting in a decline in DVT detection.
Moira A. McGevna
Student Researcher
New York University, New Jersey, United States